Penumbra Inc. PEN

What this company does

Penumbra, Inc. designs, develops, manufactures and markets products, and operates as one operating segment. As of December 31, 2025, the company had approximately 4,700 employees worldwide. The company maintains manufacturing facilities in Alameda and Roseville, California, and produces substantially all of its products in-house. The company divides its markets into thrombectomy, which includes products that treat conditions such as pulmonary embolism, deep vein thrombosis, acute limb ischemia, ischemic stroke and coronary disease, and embolization and access, which include products to treat aneurysms and to occlude vessels as well as products to access the vasculature. The Penumbra System is a fully integrated mechanical thrombectomy system consisting of reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump. The Ruby Embolization Platform consists of detachable coils that are specifically designed for peripheral applications. Penumbra, Inc. was founded in 2004.

Written from the business description in Penumbra, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.